Fundraising Fox

Shield Bio

DefunctYC S16

San Francisco, US · 28 employees · 5 known investors

Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.

Also known as Shield Diagnostics · TL Biolabs

HealthtechMedical DevicesHealthcareGenomicsNanotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S16)

FTFred Turner
Fred Turnerin𝕏Founder · CEO2018–2020

Investors · 5

Y CombinatorSan Francisco · $500K
Andreessen HorowitzreportedMenlo Park · $500K – $50M
Refactor CapitalreportedBurlingame · $1M – $2M
Soma CapitalreportedSacramento · $100K – $300K
Valia VenturesreportedLondon · $50K – $50M

In the news

Shield Bio - Company Profile, Funding & News | Goldengolden.com

Frequently asked questions

What does Shield Bio do?
Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.
Who founded Shield Bio?
Shield Bio was founded by Fred Turner.
Who are Shield Bio's investors?
Shield Bio's investors include Y Combinator, Andreessen Horowitz, Refactor Capital, Soma Capital, Valia Ventures.
Where is Shield Bio headquartered?
Shield Bio is headquartered in San Francisco, US.